finasteride has been researched along with Sex Disorders in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.27) | 18.2507 |
2000's | 5 (11.36) | 29.6817 |
2010's | 31 (70.45) | 24.3611 |
2020's | 7 (15.91) | 2.80 |
Authors | Studies |
---|---|
Irwig, MS | 4 |
Bahrick, A; Bak, M; Barbato, A; Calabrò, RS; Chubak, BM; Cosci, F; Csoka, AB; D'Avanzo, B; Diviccaro, S; Giatti, S; Goldstein, I; Graf, H; Healy, D; Hellstrom, WJG; Irwig, MS; Jannini, EA; Janssen, PKC; Khera, M; Kumar, MT; Le Noury, J; Lew-Starowicz, M; Linden, DEJ; Lüning, C; Mangin, D; Melcangi, RC; Panicker, JN; Patacchini, A; Pearlman, AM; Pukall, CF; Raj, S; Reisman, Y; Rodríguez, OWMAAS; Rubin, RS; Schreiber, R; Shipko, S; Vašečková, B; Waraich, A | 1 |
Basaria, S; Bhojani, N; Chughtai, B; Cone, EB; Elterman, DS; Herzog, P; Labban, M; Nguyen, DD; Trinh, QD; Zorn, KC | 1 |
Gray, SL; Semla, TP | 1 |
Traish, AM | 1 |
Cargnelutti, F; Carlini, T; Lenzi, A; Lombardo, F; Pallotti, F; Paoli, D; Pelloni, M; Radicioni, AF; Rossi, A; Senofonte, G | 1 |
Choi, JY; Kang, MJ; Lew, BL; Sim, WY | 1 |
Borgo, F; Cavaletti, G; Diviccaro, S; Falvo, E; Giatti, S; Macandog, AD; Melcangi, RC | 1 |
Darwin, E; Fertig, RM; Gamret, AC; Gaudi, S | 1 |
Bergfeld, W; Murad, A | 1 |
Diviccaro, S; Giatti, S; Melcangi, RC; Panzica, G | 1 |
Mehta, A; Said, MA | 1 |
Althof, S; Baas, WR; Butcher, MJ; Clemons, J; Delfino, K; Herberts, M; Holland, B; Kohler, TS; Lwin, A; McVary, KT | 1 |
Choe, SJ; Lee, S; Lee, WS; Lee, YB | 1 |
Coskuner, ER; Culha, MG; Ozkan, B | 1 |
Kajdy, A; Maksym, RB; Rabijewski, M | 1 |
Carviel, JL; Epstein, E; Foley, KA; Gupta, AK; Haber, RS | 1 |
Cohen, BE; Goldberg, JE; Ho, RS; Motosko, CC; Zakhem, GA | 1 |
Canguven, O; Talib, RA | 1 |
Kaplan, SA | 1 |
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F | 1 |
Choi, JW; Huh, CH; Jung, JY; Kim, BJ; Kwon, SH; Park, KC; Yeon, JH; Youn, SW | 1 |
Healy, D; Hogan, C; Le Noury, J; Mangin, D | 1 |
Ganzer, CA; Iqbal, F; Jacobs, AR | 1 |
Belgrano, E; Cauci, S; Di Loreto, C; La Marra, F; Mazzon, G; Trombetta, C | 1 |
Ali, AK; Etminan, M; Heran, BS | 1 |
Bortolato, M; Garcia-Segura, LM; Melcangi, RC; Traish, AM; Zitzmann, M | 1 |
Etminan, M; Flannigan, R; Guo, M; Heran, B; Kezouh, A | 1 |
Amr, S; Basaria, S; Bhasin, S; Bhawan, J; Dury, AY; Gonthier, R; Huang, G; Jasuja, R; Labrie, F; Li, Z; O'Leary, M; Pan, H; Papazian, A; Pencina, K; Serra, C; Stern, E; Storer, TW; Travison, TG; Wharton, W | 1 |
Sarvis, JA; Thompson, IM | 1 |
O'Leary, M | 1 |
Irwig, MS; Kolukula, S | 1 |
Gilling, P; Morrill, B; Nickel, JC; Rittmaster, RS; Tammela, TL; Wilson, TH | 1 |
Kuehn, BM | 1 |
Balercia, G; Corona, G; Forti, G; Maggi, M; Mannucci, E; Maseroli, E; Rastrelli, G; Sforza, A | 1 |
Gur, S; Hellstrom, WJ; Kadowitz, PJ | 1 |
Lee, M; Meehan, A; Roehrborn, CG; Waldstreicher, J | 1 |
Nehra, A | 1 |
Kuritzky, L | 1 |
Blumenstein, B; Brawley, OW; Coltman, CA; Crowley, J; Feigl, P; Ford, LG; Kramer, BS; Thompson, I; Wolf, M | 1 |
15 review(s) available for finasteride and Sex Disorders
Article | Year |
---|---|
Post-finasteride syndrome: a surmountable challenge for clinicians.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Clinical Trials as Topic; Finasteride; Humans; Male; Observational Studies as Topic; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment | 2020 |
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
Topics: 5-alpha Reductase Inhibitors; Dose-Response Relationship, Drug; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological | 2017 |
5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Breast Neoplasms; Depression; Dutasteride; Evidence-Based Medicine; Female; Fibrosis; Finasteride; Forehead; Hair; Humans; Scalp; Sexual Dysfunction, Physiological | 2018 |
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
Topics: Alopecia; Antidepressive Agents; Depression; Female; Finasteride; Humans; Iatrogenic Disease; Libido; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Syndrome | 2018 |
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Infertility, Male; Libido; Male; Sexual Dysfunction, Physiological | 2018 |
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological | 2019 |
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Libido; Male; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2019 |
Post-finasteride syndrome - does it really exist?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug-Related Side Effects and Adverse Reactions; Finasteride; Humans; Iatrogenic Disease; Male; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological | 2019 |
Sexual dysfunction in men taking systemic dermatologic medication: A systematic review.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Cyclosporine; Dermatologic Agents; Finasteride; Humans; Itraconazole; Male; Middle Aged; Prevalence; Prognosis; Risk Assessment; Sexual Dysfunction, Physiological | 2019 |
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents | 2014 |
Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Animals; Central Nervous System; Cholestenone 5 alpha-Reductase; Cognition Disorders; Depression; Diabetes Mellitus; Dutasteride; Finasteride; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Psychoses, Substance-Induced; Sexual Dysfunction, Physiological; Steroids | 2015 |
Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice.
Topics: Aged; Chemoprevention; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Placebos; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Risk; Sexual Dysfunction, Physiological | 2008 |
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prevalence; Prostatic Hyperplasia; Quality of Life; Risk Assessment; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Treatment Outcome | 2013 |
Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Male; Penile Erection; Prostatic Hyperplasia; Sexual Dysfunction, Physiological | 2005 |
Noninvasive management of lower urinary tract symptoms and sexual dysfunction associated with benign prostatic hyperplasia in the primary care setting.
Topics: Adrenergic alpha-Antagonists; Azasteroids; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Primary Health Care; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Urination Disorders | 2005 |
3 trial(s) available for finasteride and Sex Disorders
Article | Year |
---|---|
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Double-Blind Method; Dutasteride; Finasteride; Gynecomastia; Humans; Hypertension; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Treatment Outcome | 2011 |
Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome | 2003 |
Design of the Prostate Cancer Prevention Trial (PCPT).
Topics: Aged; Bias; Confounding Factors, Epidemiologic; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Random Allocation; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Sample Size; Sexual Dysfunction, Physiological; United States | 1995 |
26 other study(ies) available for finasteride and Sex Disorders
Article | Year |
---|---|
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effects.
Topics: Finasteride; Genital Diseases, Male; Humans; Male; Pharmacovigilance; Sexual Dysfunction, Physiological; Syndrome; Urological Agents | 2022 |
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
Topics: Adolescent; Antidepressive Agents; Child; Finasteride; Humans; Isotretinoin; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2022 |
Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Humans; Male; Pharmacovigilance; Sexual Dysfunction, Physiological | 2023 |
Post-finasteride syndrome.
Topics: 5-alpha Reductase Inhibitors; Finasteride; Humans; Male; Mental Disorders; Sexual Dysfunction, Physiological; Syndrome; Withholding Treatment | 2019 |
Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function.
Topics: Alopecia; Finasteride; Humans; Male; Reproduction; Retrospective Studies; Sexual Dysfunction, Physiological | 2020 |
5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Male; Middle Aged; Retrospective Studies; Sexual Dysfunction, Physiological; Treatment Outcome | 2021 |
Alterations of gut microbiota composition in post-finasteride patients: a pilot study.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Biodiversity; Cognitive Dysfunction; Correlation of Data; Depression; Drug-Related Side Effects and Adverse Reactions; Finasteride; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Physical Functional Performance; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sexual Dysfunction, Physiological | 2021 |
A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.
Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Datasets as Topic; Dose-Response Relationship, Drug; Drug Eruptions; Fatigue; Finasteride; Gynecomastia; Hearing Disorders; Humans; Libido; Male; Memory Disorders; Middle Aged; Muscle Weakness; Prostatitis; Sexual Dysfunction, Physiological; Sleep Wake Disorders; United States; United States Food and Drug Administration | 2018 |
Finasteride 1 mg in alopecia: sexual dysfunction, suicidal ideation. Providing balanced information to male patients is key.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Aged; Alopecia; Finasteride; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Suicidal Ideation; Young Adult | 2016 |
Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey-based, single-centre, controlled study.
Topics: Adolescent; Adult; Alopecia; Case-Control Studies; Dermatologic Agents; Finasteride; Humans; Libido; Middle Aged; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Young Adult | 2019 |
Persistent sexual side effects of finasteride: could they be permanent?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Humans; Male; Sexual Dysfunction, Physiological | 2013 |
Decreased alcohol consumption among former male users of finasteride with persistent sexual side effects: a preliminary report.
Topics: 5-alpha Reductase Inhibitors; Adult; Alcohol Drinking; Central Nervous System Depressants; Drinking Behavior; Ethanol; Finasteride; Humans; Male; Middle Aged; Neurotransmitter Agents; Sexual Dysfunction, Physiological; Young Adult | 2013 |
Re: inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Erectile Dysfunction; Finasteride; Humans; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sleep Wake Disorders | 2014 |
Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Azasteroids; Dutasteride; Finasteride; Hair; Humans; Male; Photography; Retreatment; Sexual Dysfunction, Physiological; Treatment Failure | 2014 |
One hundred and twenty cases of enduring sexual dysfunction following treatment.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Aged; Female; Finasteride; Humans; Isotretinoin; Keratolytic Agents; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Young Adult | 2014 |
Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
Topics: 5-alpha Reductase Inhibitors; Adult; Affective Symptoms; Alopecia; Cognition Disorders; Finasteride; Health Surveys; Humans; Internet; Long Term Adverse Effects; Male; Middle Aged; Pilot Projects; Sexual Dysfunction, Physiological; Young Adult | 2015 |
Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Case-Control Studies; Finasteride; Foreskin; Humans; Immunohistochemistry; Male; Middle Aged; Receptors, Androgen; Retrospective Studies; Sexual Dysfunction, Physiological; Testosterone; Young Adult | 2014 |
Androgen levels and semen parameters among former users of finasteride with persistent sexual adverse effects.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia Areata; Dihydrotestosterone; Finasteride; Humans; Male; Sexual Dysfunction, Physiological; Sperm Count; Sperm Motility; Spermatozoa; Testosterone | 2014 |
Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Databases, Factual; Finasteride; Humans; Male; Middle Aged; Pharmacovigilance; Sexual Dysfunction, Physiological; Suicidal Ideation; Young Adult | 2015 |
Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Cohort Studies; Finasteride; Humans; Middle Aged; Omeprazole; Retrospective Studies; Sexual Dysfunction, Physiological; Time Factors | 2016 |
Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgens; Depressive Disorder, Major; Finasteride; Gene Expression; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Androgen; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Young Adult | 2016 |
By the way, doctor. Finasteride has been prescribed for my BPH. I think that the most frequent side effect is erectile dysfunction or loss of sexual desire. Would Levita or a similar drug (like Viagra or Cialis) overcome the side effects of finasteride
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Drug Synergism; Enzyme Inhibitors; Finasteride; Humans; Imidazoles; Male; Piperazines; Prostatic Hyperplasia; Purines; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2009 |
Persistent sexual side effects of finasteride for male pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Chronic Disease; Dose-Response Relationship, Drug; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Sexual Dysfunction, Physiological; Young Adult | 2011 |
Prostate, baldness drugs linked to sexual dysfunction.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Labeling; Finasteride; Humans; Infertility, Male; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; United States; United States Food and Drug Administration | 2012 |
Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Case-Control Studies; Cholestenone 5 alpha-Reductase; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Hyperplasia; Retrospective Studies; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Testosterone | 2012 |
Persistent sexual side effects of finasteride: could they be permanent?
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Chronic Disease; Finasteride; Humans; Male; Middle Aged; Prospective Studies; Sexual Dysfunction, Physiological | 2012 |